Healthcare Eli Lilly Completes Acquisition of POINT BiopharmaPoint Biopharma Global Inc. is a radiopharmaceutical company. December 27, 2023
Healthcare Moderna to Pay Immatics Up to $1.8B in Cancer-Drug DealThe company is working with Merck & Co. on a personalized cancer vaccine for melanoma and other tumors, but testing could take years to complete. September 11, 2023
Private Equity TA Associates Makes Strategic Growth Investment in DiatechDiatech Pharmacogenetics is a pharmacogenetics and cancer medicine diagnostics company. April 26, 2023
Healthcare Pfizer Purchases Cancer Drugmaker Seagen for $43BSeagen develops antibody-drug conjugates, which deliver potent cancer-killing drugs. March 13, 2023
Technology Merck Is in Advanced Talks to Acquire Biotech Firm SeagenSeagen develops cancer therapies using antibody conjugate and sugar-engineered antibody technologies. July 7, 2022